Cargando…
Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey
SIMPLE SUMMARY: Selection of appropriate stage II colon cancer patients for adjuvant chemotherapy (AC) is controversial. A novel immune response classifier has previously been validated to refine patient selection, but its impact on oncologist treatment planning had yet to be described. In this surv...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582441/ https://www.ncbi.nlm.nih.gov/pubmed/34771628 http://dx.doi.org/10.3390/cancers13215467 |